ClinicalTrials.Veeva

Menu

AI Activity Study in Patients With Elevated Blood Pressure

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Terminated

Conditions

Hypertension

Treatments

Behavioral: 10,000 steps
Behavioral: Artificial Intelligence (AI) Activity

Study type

Interventional

Funder types

Other

Identifiers

NCT03969056
18-26452

Details and patient eligibility

About

In this pilot RCT, a total of 40 adults with hypertension will be randomized to either an artificial intelligence (AI) physical activity intervention group or an active control group with a 1 to 1 ratio after completing a 2-week run-in period and 4-week training. The AI intervention group will receive an automated and personalized daily step goal intervention involving a sophisticated activity analytics algorithm using advanced statistics and machine learning, while the active control group will receive a standardized and fixed 10,000 daily steps goal. Both groups will receive an identical smartphone app (app content differs between the two groups) and ActiGraph GT9X Link to assess objectively measured physical activity (primary outcome) during the study period.

Enrollment

7 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age ≥18 years
  • systolic blood pressure between 130 mmHg to 180 mmHg or/and diastolic blood *pressure between 80 to 100 mmHg in a research office
  • speaking and reading English
  • being physically inactive at work or during leisure time and willing to be physically active
  • having an iPhone 8 or newer or an Android Lollipop or newer

Exclusion criteria

  • self-reported diagnosis of coronary heart disease, medical condition or other physical problem necessitating special attention in an exercise program (e.g., cancer, eating disorder, uncontrolled diabetes)
  • current participation in a lifestyle modification program or research study
  • self-report of being currently pregnant.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

7 participants in 2 patient groups

Artificial Intelligence (AI) Activity group
Experimental group
Description:
Participants in this group receive an AI based intervention (automated and personalized daily step goal intervention involving a sophisticated activity analytics algorithm using advanced statistics and machine learning and message)
Treatment:
Behavioral: Artificial Intelligence (AI) Activity
Control group
Active Comparator group
Description:
Participants in this group receive a standardized and fixed 10,000 daily steps goal intervention.
Treatment:
Behavioral: 10,000 steps

Trial contacts and locations

1

Loading...

Central trial contact

Kiley Charbonneau; Yoshimi Fukuoka, PhD, RN, FAAN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems